Physician profile
Manlio A Goetzl
NPI 1932229853
$4,114.65
in general payments reported to CMS, 2019-2025
26 companies · $686 in 2025
The $686 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $283 · 2021: $876 · 2022: $711 · 2023: $527 · 2024: $661 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,873.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $805.28 | 2019-2025 | Provenge |
| Pfizer INC. | $777.19 | 2019-2025 | |
| Astellas Pharma US INC | $400.02 | 2019-2022 | |
| Abbvie INC. | $382.28 | 2020-2025 | |
| Endo Pharmaceuticals INC. | $370.74 | 2019-2023 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $358.96 | 2019-2024 | Erleada, Akeega, Abiraterone Acetate |
| Myovant Sciences INC. | $149.16 | 2021-2022 | |
| Neotract INC. | $109.09 | 2019-2020 | |
| Procept Biorobotics Corporation | $98.73 | 2024-2025 | Aquabeam System |
| Sumitomo Pharma America, INC. | $79.12 | 2023 | Orgovyx |
| Boston Scientific Corporation | $76.57 | 2019-2024 | |
| Teleflex LLC | $73.29 | 2022-2025 | Barrigel, Urolift |
| Dornier Medtech America, INC | $64.10 | 2021 | |
| Olympus America INC. | $57.93 | 2020-2025 | Itind System |
| Allergan, INC. | $38.76 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $37.28 | 2021-2023 | Jelmyto |
| Coloplast Corp | $35.00 | 2025 | |
| Progenics Pharmaceuticals, INC. | $34.85 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $34.60 | 2022 | |
| Merck Sharp & Dohme LLC | $24.52 | 2022 | |
| Dentsply Ih INC. | $23.01 | 2020 | |
| Laborie Medical Technologies Corp. | $18.35 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Smith+Nephew, INC. | $17.87 | 2021 | |
| 180 Medical, INC. | $17.29 | 2021 | |
| Axonics, INC. | $16.75 | 2023 | Axonics |
| Avadel Specialty Pharmaceuticals, LLC | $13.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manlio Goetzl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.